NCT06547827

Brief Summary

Rehabilitation after stroke often employs Robot and Allied Digital Technologies (RADTs), yet evidence on their effectiveness remains inconclusive due to study heterogeneity and limited sample sizes. This multicentre randomized controlled pragmatic trial aims at comprehensively and accurately assessing the effectiveness of rehabilitation mediated by RADTs after a stroke, compared to traditional rehabilitation, also considering economic sustainability.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
596

participants targeted

Target at P75+ for not_applicable stroke

Timeline
3mo left

Started Aug 2024

Typical duration for not_applicable stroke

Geographic Reach
1 country

13 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Aug 2024Jul 2026

First Submitted

Initial submission to the registry

July 29, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

August 12, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

1.4 years

First QC Date

July 29, 2024

Last Update Submit

February 10, 2025

Conditions

Keywords

rehabilitationrobotics

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in the modified Barthel Index

    The modified Barthel Index for Activities of Daily Living is a validated ordinal scale which measures a person's ability to complete activities of daily living (ADL). Scores range from 0 (total dependence) to 100 (total independence).

    baseline; within 24 hours from the 25th rehabilitation session

Secondary Outcomes (24)

  • Fugl-Meyer Assessment for the upper extremities - motor function

    baseline; within 24 hours from the 25th rehabilitation session

  • Fugl-Meyer Assessment for the upper extremities - sensory function

    baseline; within 24 hours from the 25th rehabilitation session

  • Fugl-Meyer Assessment for the lower extremities - motor function

    baseline; within 24 hours from the 25th rehabilitation session

  • Fugl-Meyer Assessment for the lower extremities - sensory function

    baseline; within 24 hours from the 25th rehabilitation session

  • Berg Balance Scale

    baseline; within 24 hours from the 25th rehabilitation session

  • +19 more secondary outcomes

Other Outcomes (28)

  • premorbid Modified Rankin Scale

    At baseline

  • Life Time Physical Activity Questionnaire

    At baseline

  • Cognitive Reserve Index

    At baseline

  • +25 more other outcomes

Study Arms (2)

Integrated Treatment with Robotic & Technological Devices (RADTs)

EXPERIMENTAL

This intervention employs various RADTs to target the following domains: a) upper limb sensorimotor abilities; b) lower limb sensorimotor abilities and gait; c) balance; and d) cognitive abilities. For upper limb sensorimotor function, we will use planar end-effector robots, exoskeletons, or electromechanical systems for shoulder, elbow, and wrist rehabilitation; end-effector robots or exoskeletons for hand rehabilitation; and sensor-based devices for comprehensive upper limb treatment. For lower limb sensorimotor function, we will utilize end-effector robots or exoskeletons and treadmills with body-weight support systems. Balance training will involve stabilometric platforms and sensor-based systems. Cognitive functions will be addressed using digital systems, sensor-based devices, and virtual reality programs. All devices must have a CE mark for medical devices and be used according to the manufacturer's specifications.

Other: robotic rehabilitation

Traditional Treatment

ACTIVE COMPARATOR

In the control group, subjects will undergo a standard traditional rehabilitation program without the use of RADTs, focusing on the following domains:a) upper limb sensorimotor abilities; b) lower limb sensorimotor abilities and gait; c) balance; and d) cognitive abilities, using traditional methods of physiotherapy and cognitive rehabilitation.

Other: traditional rehabilitation

Interventions

Treatment will occur in a gym equipped with devices for all the domains, with two physiotherapists supervising groups of 4 to 6 patients, depending on their clinical severity. Patients will undergo a total of 25 sessions, each lasting 45 minutes, with the following frequency: * 5 times a week for 5 weeks, for inpatients; * 3 times a week for 8.3 weeks, for outpatients.

Integrated Treatment with Robotic & Technological Devices (RADTs)

A physiotherapist-to-patient ratio of 1:1 is provided for the treatment in all participating centres. Patients will undergo a total of 25 sessions, each lasting 45 minutes, with the following frequency: * 5 times a week for 5 weeks, for inpatients; * 3 times a week for 8.3 weeks, for outpatients.

Traditional Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First-ever diagnosis of ischemic or haemorrhagic stroke confirmed by Computed Tomography or Magnetic Resonance Imaging;
  • Age 18 years and over;
  • Time since the event equal to or less than 6 months;
  • Mild to severe impairment of the upper limb (motor section of the Fugl-Meyer Assessment of Upper Extremity ≤ 58) and/or mild to severe impairment of the lower limb (score on the Functional Ambulation Categories scale ≤ 4) and/or mild to severe impairment of balance (Berg Balance Scale ≤ 45);
  • Clinical stability allowing transfer to the gym and execution of the planned treatments.

You may not qualify if:

  • Clinical instability;
  • Behavioral/cognitive disorders preventing adequate patient compliance with both traditional and robotic rehabilitation treatment (severe cognitive deficit, Montreal Cognitive Assessment \<10);
  • Rigidity or hypertonia (Modified Ashworth Scale \> 3) in the plegic/paretic limb;
  • Serious uncorrectable visual impairments preventing the patient from performing treatment with technological and/or robotic devices;
  • Pregnant women;
  • Refusal to sign the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Fondazione Don Carlo Gnocchi, Centro Gala

Acerenza, Italy

RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Bari, Italy

NOT YET RECRUITING

IRCCS Ospedale Policlinico San Martino,

Genova, Italy

RECRUITING

Fondazione Don Carlo Gnocchi, IRCCS Santa Maria Nascente

Milan, Italy

NOT YET RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Milan, Italy

NOT YET RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Montescano, Italy

RECRUITING

IRCCS Fondazione Mondino

Pavia, Italy

RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Pavia, Italy

RECRUITING

Fondazione Don Carlo Gnocchi, Centro Santa Maria della Provvidenza

Roma, Italy

RECRUITING

Fondazione Don Carlo Gnocchi, Centro Santa Maria al Mare

Salerno, Italy

NOT YET RECRUITING

Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo

Sant'Angelo dei Lombardi, Italy

RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Telese Terme, Italy

NOT YET RECRUITING

Fondazione Don Carlo Gnocchi, Polo specialistico riabilitativo

Tricarico, Italy

RECRUITING

Related Publications (1)

  • Aprile IG, Germanotta M, Fasano A, Siotto M, Mauro MC, Pavan A, Nicora G, Sgandurra G, Malovini A, Oreni L, Dubbini N, Parimbelli E, Comande G, Lunetta C, Fiore P, De Icco R, Trompetto C, Trieste L, Turchetti G, Quaglini S, Messa C; STROKEFIT4 Study Group. Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4). J Clin Med. 2025 Apr 15;14(8):2692. doi: 10.3390/jcm14082692.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Irene G Aprile

    IRCCS Fondazione Don Carlo Gnocchi

    STUDY DIRECTOR
  • Irene G Aprile

    IRCCS Fondazione Don Carlo Gnocchi

    PRINCIPAL INVESTIGATOR
  • Christian Lunetta

    IRCCS Istituti Clinici Scientifici Maugeri

    PRINCIPAL INVESTIGATOR
  • Roberto De Icco

    IRCCS Fondazione Mondino

    PRINCIPAL INVESTIGATOR
  • Carlo Trompetto

    IRCCS Ospedale Policlinico San Martino

    PRINCIPAL INVESTIGATOR
  • Silvana Quaglini

    Università di Pavia

    PRINCIPAL INVESTIGATOR
  • Giuseppe Turchetti

    Scuola Superiore Sant'Anna di Pisa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Irene G Aprile, MD, PhD

CONTACT

Marco Germanotta, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2024

First Posted

August 9, 2024

Study Start

August 12, 2024

Primary Completion

January 1, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

February 12, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in the publication will be shared.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning six months after the publication, with no end date.
Access Criteria
Access will be provided to the general scientific community and any interested researchers, for any type of analysis or secondary research use. The data will be made available on a public data-sharing platform such as Zenodo, or Figshare.

Locations